Tharimmune strengthens strategic leadership with the appointment of vincent lopriore to its board of directors

Bridgewater, nj / access newswire / april 15, 2025 / tharimmune, inc. (nasdaq:thar), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of vincent lopriore, founder of gravitas capital and co-founder of president street global, to its board of directors, increasing the size of the board to seven directors. this appointment strengthens tharimmune's strategic leadership and will support the company's next phase of growth and product development.
THAR Ratings Summary
THAR Quant Ranking